This company has been acquired
Pardes Biosciences Dividende
Zukünftiges Wachstum Kriterienprüfungen 0/6
Pardes Biosciences does not have a record of paying a dividend.
Wichtige Informationen
n/a
Dividendenausschüttung
n/a
Ausschüttungsquote
| Durchschnittlicher Branchenertrag | 2.8% |
| Nächster Dividendenzahlungstermin | n/a |
| Ex-Dividendendatum | n/a |
| Dividende pro Aktie | n/a |
| Gewinn pro Aktie | -US$1.25 |
| Erwartete Dividendenrendite in 3 Jahren | n/a |
Aktuelle Dividendenentwicklung
Keine Aktualisierungen
Recent updates
We're Keeping An Eye On Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Rate
Jul 18
Here's Why We're Watching Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Situation
Jan 20We Think Pardes Biosciences (NASDAQ:PRDS) Needs To Drive Business Growth Carefully
Oct 01Pardes begins phase 2 trial of oral drug PBI-0451 for COVID-19
Sep 13Pardes Biosciences GAAP EPS of -$0.48
Aug 15Pardes Biosciences (NASDAQ:PRDS) Is In A Good Position To Deliver On Growth Plans
Jun 14Pardes Biosciences: Advancing A Viral Protease Inhibitor Platform
Jan 21Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: Insufficient data to determine if PRDS's dividends per share have been stable in the past.
Wachsende Dividende: Insufficient data to determine if PRDS's dividend payments have been increasing.
Dividendenrendite im Vergleich zum Markt
| Pardes Biosciences Dividendenrendite im Vergleich zum Markt |
|---|
| Segment | Dividendenrendite |
|---|---|
| Unternehmen (PRDS) | n/a |
| Untere 25 % des Marktes (US) | 1.6% |
| Markt Top 25 % (US) | 4.8% |
| Branchendurchschnitt (Biotechs) | 2.8% |
| Analystenprognose in 3 Jahren (PRDS) | n/a |
Bemerkenswerte Dividende: Unable to evaluate PRDS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hohe Dividende: Unable to evaluate PRDS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Barausschüttung an die Aktionäre
Cashflow-Deckung: Unable to calculate sustainability of dividends as PRDS has not reported any payouts.